The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
- PMID: 32283144
- PMCID: PMC7195158
- DOI: 10.1016/j.jinf.2020.03.062
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
Abstract
Objectives: An outbreak of novel coronavirus in 2019 threatens the health of people, and there is no proven pharmacological treatment. Although corticosteroids were widely used during outbreaks of severe acute respiratory syndrome and Middle East respiratory syndrome, their efficacy remainedhighly controversial. We aimed to further evaluate the influence of corticosteroids on patients with coronavirus infection.
Methods: We conducted a comprehensive search of literature published in PubMed, Embase, Cochrane library, and China National Knowledge Infrastructure (CNKI) from January 1, 2002 to March 15, 2020. All statistical analyses in this study were performed on stata14.0.
Results: A total of 5270 patients from 15 studies were included in this meta-analysis. The result indicated that critical patients were more likely to require corticosteroids therapy (risk ratio [RR] = 1.56, 95% confidence interval [CI] = 1.28-1.90, P<0.001). However, corticosteroid treatment was associated with higher mortality (RR = 2.11, 95%CI = 1.13-3.94, P = 0.019), longer length of stay (weighted mean difference [WMD] = 6.31, 95%CI = 5.26-7.37, P<0.001), a higher rate of bacterial infection (RR = 2.08, 95%CI = 1.54-2.81, P<0.001), and hypokalemia (RR = 2.21, 95%CI = 1.07-4.55, P = 0.032) but not hyperglycemia (RR = 1.37, 95%CI=0.68-2.76, P = 0.376) or hypocalcemia (RR = 1.35, 95%CI = 0.77-2.37, P = 0.302).
Conclusions: Patients with severe conditions are more likely to require corticosteroids. Corticosteroid use is associated with increased mortality in patients with coronavirus pneumonia.
Keywords: COVID-19; Coronavirus; Meta-analysis; corticosteroid treatment.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest No authors have competing interests in this research.
Figures





Comment in
-
Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.J Infect. 2020 Aug;81(2):e89-e90. doi: 10.1016/j.jinf.2020.05.023. Epub 2020 May 14. J Infect. 2020. PMID: 32417314 Free PMC article. No abstract available.
-
The association between corticosteroid uses and mortality among severe COVID-19 patients.J Infect. 2021 Feb;82(2):e24. doi: 10.1016/j.jinf.2020.09.005. Epub 2020 Sep 12. J Infect. 2021. PMID: 32931775 Free PMC article. No abstract available.
-
Early, low-dose, short-term methylprednisolone decreased the mortality in critical COVID-19 patients: A multicenter retrospective cohort study.J Infect. 2021 Apr;82(4):84-123. doi: 10.1016/j.jinf.2020.11.001. Epub 2020 Nov 8. J Infect. 2021. PMID: 33176176 Free PMC article. No abstract available.
-
Outcomes of Covid-19 organizing pneumonia in critically ill patients.J Infect. 2021 Oct;83(4):496-522. doi: 10.1016/j.jinf.2021.06.025. Epub 2021 Jul 1. J Infect. 2021. PMID: 34217780 Free PMC article. No abstract available.
References
-
- Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group. 2020:2020.02.07.937862.
-
- WHO. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February2020. Available from:https://www.who.int/zh/dg/speeches/detail/who-director-general-s-remarks....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical